Persistence of FLT3-TKD in Blood Prior to Allogeneic Transplant Is Associated with Increased Relapse and Death in Adults with AML in First Remission

MLA

Hegde, Pranay S., et al. “Persistence of FLT3-TKD in Blood Prior to Allogeneic Transplant Is Associated with Increased Relapse and Death in Adults with AML in First Remission.” Blood, vol. 142, no. 1, Number 1 Supplement 1, Nov. 2023, p. 2941. EBSCOhost, https://doi.org/10.1182/blood-2023-180121.

APA

Hegde, P. S., Andrew, G., Gui, G., Ravindra, N., Mukherjee, D., Wong, Z., Auletta, J. J., El Chaer, F., Corner, A., Devine, S. M., Jimenez Jimenez, A. M., de Lima, M., Litzow, M. R., Kebriaei, P., Saber, W., Spellman, S. R., Zeger, S. L., Page, K. M., Dillon, L. W., & Hourigan, C. S. (2023). Persistence of FLT3-TKD in Blood Prior to Allogeneic Transplant Is Associated with Increased Relapse and Death in Adults with AML in First Remission. Blood, 142(1, Number 1 Supplement 1), 2941. https://doi.org/10.1182/blood-2023-180121

Chicago

Hegde, Pranay S., Georgia Andrew, Gege Gui, Niveditha Ravindra, Devdeep Mukherjee, Zoe Wong, Jeffery J. Auletta, et al. 2023. “Persistence of FLT3-TKD in Blood Prior to Allogeneic Transplant Is Associated with Increased Relapse and Death in Adults with AML in First Remission.” Blood 142 (1, Number 1 Supplement 1): 2941. doi:10.1182/blood-2023-180121.